{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:20:38Z","timestamp":1760955638307,"version":"3.37.3"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1053\/j.jvca.2016.03.157","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T08:41:04Z","timestamp":1459672864000},"page":"1698-1708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["CASE 11\u20142016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?"],"prefix":"10.1053","volume":"30","author":[{"given":"Michael K.","family":"Essandoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A.","family":"Dalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry S.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antolin S.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Otey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2016.03.157_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/ALN.0000000000000113","volume":"120","author":"Botto","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2016.03.157_bib2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial","volume":"371","author":"Devereaux","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2016.03.157_bib3","doi-asserted-by":"crossref","unstructured":"Bittl JA, Baber U, Bradley SM et al: Duration of dual antiplatelet therapy: A systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol. 2016. http:\/\/dx.doi.org\/10.1016\/j.jacc.2016.03.512. [Epub ahead of print]","DOI":"10.1016\/j.jacc.2016.03.512"},{"key":"10.1053\/j.jvca.2016.03.157_bib4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2016.03.157_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: A systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: A randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): A randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2016.03.157_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2013.08.725","article-title":"Stent thrombosis with drug-eluting stents: Is the paradigm shifting?","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6-versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: The randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.11.002","article-title":"Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents","volume":"169","author":"Garg","year":"2015","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2016.03.157_bib12","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2016.03.157_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/bja\/aem209","article-title":"Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction","volume":"99","author":"Chassot","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2016.03.157_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.0000050621.67499.7D","article-title":"Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity","volume":"107","author":"Sambola","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib16","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2011.03.005","article-title":"Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial","volume":"57","author":"Yeung","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib18","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: The SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib19","first-page":"149","article-title":"A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease","volume":"7","author":"Bennett","year":"2013","journal-title":"Biologics"},{"key":"10.1053\/j.jvca.2016.03.157_bib20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2016.03.157_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2016.03.157_bib22","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/CIRCULATIONAHA.107.707331","article-title":"Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents","volume":"116","author":"Doyle","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcin.2015.10.001","article-title":"Benefits and risks of extended dual antiplatelet therapy after everolimus-eluting stents","volume":"9","author":"Hermiller","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jacc.2013.09.043","article-title":"Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia)","volume":"63","author":"Campo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2009.11.017","article-title":"Perioperative management of patients with drug-eluting stents","volume":"3","author":"Abualsaud","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib26","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","article-title":"Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction","volume":"65","author":"Yeh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib27","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2016.03.157_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ccd.25507","article-title":"Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: A weighted meta-analysis of 280 patients from eight studies","volume":"85","author":"Warshauer","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2016.03.157_bib30","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIR.0000000000000105","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Fleisher","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib31","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2016.03.157_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2016.03.157_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2016.03.157_bib34","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jacc.2009.01.050","article-title":"Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial","volume":"53","author":"Weisz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2009.10.003","article-title":"Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of de novo coronary disease using a single paclitaxel-eluting stent)","volume":"2","author":"Ellis","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2011.02.016","volume":"57","author":"Stone","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib38","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","article-title":"Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial","volume":"48","author":"Kandzari","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jcin.2009.10.009","volume":"2","author":"Eisenstein","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): A randomised controlled superiority trial","volume":"375","author":"Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2016.03.157_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents","volume":"5","author":"Maeng","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib42","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)60405-0","article-title":"Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): A multicentre, open-label, randomised superiority trial","volume":"383","author":"Maeng","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2016.03.157_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacc.2009.08.067","article-title":"A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial","volume":"55","author":"Leon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cfinal\u201d 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2016.03.157_bib45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","volume":"56","author":"Park","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjcard.2004.11.029","article-title":"Risks of noncardiac surgery after coronary stenting","volume":"95","author":"Reddy","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib47","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: A pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2016.03.157_bib48","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: A phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2016.03.157_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2012.04.016","article-title":"Safety of \u201cbridging\u201d with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery","volume":"110","author":"Rassi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HPC.0b013e31826c53cd","article-title":"Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation","volume":"11","author":"Huang","year":"2012","journal-title":"Crit Pathw Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ahj.2013.05.006","article-title":"Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States","volume":"166","author":"Rao","year":"2013","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2016.03.157_bib53","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000069943.41206.BD","article-title":"Inflammation, neointimal hyperplasia, and restenosis: As the leukocytes roll, the arteries thicken","volume":"107","author":"Shah","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib54","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib55","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2011.12.042","article-title":"Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: Results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"59","author":"Dangas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib56","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib57","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2016.03.157_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2016.03.157_bib59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2015.05.053","article-title":"Duration of dual antiplatelet therapy after coronary stenting: A review of the evidence","volume":"66","author":"Montalescot","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib60","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: A mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2016.03.157_bib61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jama.2015.1671","article-title":"Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: The dual antiplatelet therapy randomized clinical trial","volume":"313","author":"Kereiakes","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2016.03.157_bib62","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.jacc.2014.09.073","article-title":"What to do when a patient with coronary stents needs surgery?","volume":"64","author":"Brilakis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2016.03.157_bib63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077016300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077016300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T15:20:36Z","timestamp":1536852036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077016300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1053077016300106"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2016.03.157","relation":{},"ISSN":["1053-0770"],"issn-type":[{"type":"print","value":"1053-0770"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CASE 11\u20142016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2016.03.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}